Ticker
BFRICompany Name
BIOFRONTERA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -15.35M | -39.16% | $ 39.19M |
3/31/2025 | $ -9.71M | -25.56% | $ 38M |
12/31/2024 | $ -14.55M | -38.99% | $ 37.32M |
9/30/2024 | $ -9.39M | -26.55% | $ 35.36M |
6/30/2024 | $ -9.97M | -28.3% | $ 35.24M |
3/31/2024 | $ -20.14M | -60.55% | $ 33.25M |
12/31/2023 | $ -18.59M | -54.55% | $ 34.07M |
9/30/2023 | $ -24.58M | -73.12% | $ 33.62M |
6/30/2023 | $ -20.98M | -72.23% | $ 29.05M |
3/31/2023 | $ -12.17M | -44% | $ 27.66M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for BIOFRONTERA INC is calculated as follows: EBITDA [ $ -8.04M ] / Revenues [ $ 22.42M ]
(=) EBITDA % [ -35.85% ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.29K |
---|---|
min | -75.07% |
max | 97.73% |
average | 16.12% |
median | 14.72% |
std | 26.88% |